昭衍新药 (603127.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

69.1x

Market Cap

CNY 34.76B

MomentumView details →

1D Return

−5.85%

YTD Return

+27.39%

RSI (14)

43.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

69.1x

Market Cap

CNY 34.76B

RSI (14)

43.7

MomentumView details →

1D Return

−5.85%

YTD Return

+27.39%

ProfitabilityView details →

Gross Margin

19.32%

Net Margin

29.36%

EBITDA Margin

27.85%

ROE (TTM)

5.79%

ROA (TTM)

4.93%

Asset Turnover

0.17x

GrowthView details →

Revenue YoY

−14.86%

EPS YoY

+30.04%

FCF YoY

+52.06%

Revenue CAGR 3Y

−9.92%

EPS CAGR 3Y

−34.75%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.67

EPS Surprise

41.71%

Beats (12Q)

1/12

Next Q EPS Est

CNY 0.03

Avg Surprise (4Q)

41.71%

Rev Surprise

−0.98%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

4.02x

Quick Ratio

2.78x

Div Yield

0.27%

Div Rate

CNY 0.12

Div Growth 1Y

+300.00%

Financials snapshotView financials →

Revenue (TTM)

1.69B

Net Income (TTM)

495.08M

Op. CF (TTM)

507.03M

Next earningsNov 4, 2026 →

Latest newsMore news →

Joinn Laboratories released its 2026 interim report on August 28, reporting net profit attributable to shareholders of 748 million yuan, up 1126.8% year-on-year, and revenue of 704 million yuan, up 5.27% year-on-year.7d ago

Joinn Laboratories (06127) issued a profit alert, expecting a significant increase in net profit for the first half of 2026 due to a rise in biological asset market prices.52d ago

Similar companies

Illumina, Inc.ILMN Hangzhou Tigermed Consulting Co., Ltd.03347.HK Waters CorporationWAT IDEXX Laboratories, Inc.IDXX Agilent Technologies, Inc.A IQVIA Holdings Inc.IQV Find similar companies →

Latest newsMore news →

Joinn Laboratories released its 2026 interim report on August 28, reporting net profit attributable to shareholders of 748 million yuan, up 1126.8% year-on-year, and revenue of 704 million yuan, up 5.27% year-on-year.7d ago Joinn Laboratories (06127) issued a profit alert, expecting a significant increase in net profit for the first half of 2026 due to a rise in biological asset market prices.52d ago